Medication info
LansTer Capsules (Lansoprazole)

LansTer Capsules (Lansoprazole)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole Granules›353mg / 1 capsule
Manufacturer / importer
International Pharmaceutical Co., Ltd.
Appearance
White to light brown granules filled in a white hard capsule with a white top and bottom.
Packaging
30 capsules/bottle
Approval status
Active

MFDS item code 200200322 · Notified 2002.12.18 · Insurance code 643701050

Summary

Main use
Treatment and prevention of gastric and duodenal ulcers and eradication of Helicobacter pylori; treatment of reflux disease; suppression of excessive gastric acid secretion
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure that the entire dose is taken, rinse the glass with 2 times or more juice and drink immediately. Do not chew or crush this medicine after opening the capsule. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days as needed. Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance treatment after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies from patient to patient. Treatment in adults is usually initiated at 60 mg once daily. Adjust the dose according to the patient's needs and continue treatment for as long as it is clinically effective. Doses of 90 mg per administration up to twice daily have been used. If the daily dose exceeds 120 mg, administer it in divided doses. Since clearance of this medicine is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer cautiously, including dose adjustment as needed.
Child dose
Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
International Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of gastric and duodenal ulcers and eradication of Helicobacter pylori; treatment of reflux disease; suppression of excessive gastric acid secretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • recurrence of duodenal ulcer
  • NSAIDs-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion conditions.
View approved original text

This medication is used for short-term treatment of active duodenal ulcers and active benign gastric ulcers, and prevents recurrence of duodenal ulcers by eradicating Helicobacter pylori. It is also effective as maintenance therapy after treatment of duodenal ulcers and helps treat NSAIDs-induced gastric ulcers and reduce the risk of occurrence. It is used for short-term treatment of gastroesophageal reflux disease and erosive esophagitis, as well as for maintenance after treatment. Finally, it is effective in controlling pathological gastric acid hypersecretion conditions such as Zollinger-Ellison syndrome. Overall, it is widely used for the treatment and prevention of various gastrointestinal diseases.

How to take

Adult dose

This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure that the entire dose is taken, rinse the glass with 2 times or more juice and drink immediately. Do not chew or crush this medicine after opening the capsule. Short-term treatment of active duodenal ulcer: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days as needed. Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance treatment after treatment of duodenal ulcer: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance treatment after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The lansoprazole dosage for pathological hypersecretory conditions varies from patient to patient. Treatment in adults is usually initiated at 60 mg once daily. Adjust the dose according to the patient's needs and continue treatment for as long as it is clinically effective. Doses of 90 mg per administration up to twice daily have been used. If the daily dose exceeds 120 mg, administer it in divided doses. Since clearance of this medicine is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer cautiously, including dose adjustment as needed.

Child dose

Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be administered to certain patients. Patients with allergies or hypersensitivity to this medication or its components, or to benzimidazole derivatives, may face risks when using this medication. Patients allergic to penicillin or macrolide antibiotics also need caution when taking this medication together. Patients taking certain heart-related medications, those using HIV protease inhibitors, pregnant women, and those with lactose intolerance should avoid this medication. When using this medication, it should be administered cautiously to individuals with a history of drug hypersensitivity, patients with poor liver function, elderly patients, breastfeeding women, and children. This medication can cause serious adverse effects such as severe allergic reactions, blood abnormalities, liver dysfunction, severe skin reactions, pneumonia, nephritis, etc., hence, administration should be immediately stopped and medical attention sought if any abnormal symptoms appear. Common side effects such as headache and diarrhea can occur, with increased incidence of diarrhea, especially during high-dose administration. Long-term use may report vitamin B12 deficiency, hypomagnesemia, increased risk of fractures, thus regular monitoring is required. This medication suppresses gastric acid secretion and may affect the absorption of other medications, so interactions with other medications being taken should be noted. During pregnancy, it should be avoided as it may pose risks to the fetus. In breastfeeding women, either administration should be avoided or breastfeeding should be discontinued. Safety has not been sufficiently established for children, hence cautious use is required. In elderly patients, it is recommended to start from a lower dose due to decreased physical function. In case of overdose, gastric lavage or symptomatic treatment may be required; this medication is not removed by dialysis. For storage, it should be kept in a tightly closed container away from children, and should not be transferred to other containers, as it can easily break. This medication may mask symptoms of malignant tumors; therefore, consultation with a specialist is recommended if symptoms such as weight loss, recurrent vomiting, hematemesis, or melena occur. During long-term use, it's important to administer the minimum effective dose for the appropriate duration under a doctor's guidance.

Side effects

Anaphylactic reaction, generalized rash, facial swelling, shortness of breath, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, AST elevation, ALT elevation, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membranous colitis, bloody stools, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, malignancy, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stools, enteritis, gastritis, gastric abnormalities, gastrointestinal disease, gastrointestinal bleeding, loss of appetite, bezoar, pyloric spasms, cholelithiasis, constipation, polydipsia, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, discoloration of stools, bloating, gastric nodules, gastric fundic polyps, gastroenteritis, gastrointestinal hemorrhage, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, tongue disease, glossitis, gum bleeding, irritability, colitis, vomiting, nausea, gastrointestinal candidiasis, rectal disease, rectal bleeding, diabetes, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disease, joint disease, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, muscle weakness, ptosis, synovitis, anxiety, amnesia, unease, confusion, depression, dizziness, syncope, hallucinations, hemiplegia, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory disturbances, abnormal thinking, seizures, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory loss syndrome, insomnia, sleep disorder, drowsiness, tremors, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disease, skin cancer, skin disease, sweating, abnormal visual field, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disease, eye disease, glaucoma, dysosmia, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, taste alteration, tinnitus, visual field constriction, urinary disturbance, renal pain, penile disease, testicular disease, urethral pain, polyuria, frequency of urination, residual urine, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, hepatic toxicity, pancreatitis, taste disturbance, aplastic anemia, leukopenia, neutropenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorder, urinary retention, AST elevation, ALP elevation, LDH elevation, γ-GTP elevation, weakness, hyponatremia, total cholesterol elevation, total cholesterol reduction, tongue paralysis, lip paralysis, limb paralysis, abdominal pain, looser stools, feelings of abdominal fullness, stomatitis, heartburn, gastroesophageal reflux, triglyceride elevation, uric acid elevation, positive urine protein, positive urine glucose, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, at a temperature between 1°C and 30°C. By storing it this way, the medication's efficacy can be maintained and used safely.

Appearance and packaging

Appearance

White to light brown granules filled in a white hard capsule with a white top and bottom.

Package unit

30 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.